-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Achilles Therapeutics plc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2022 to Q2 2024.
- Achilles Therapeutics plc Operating Income (Loss) for the quarter ending June 30, 2024 was -$17.8M, a 1.62% increase year-over-year.
- Achilles Therapeutics plc annual Operating Income (Loss) for 2023 was -$75.3M, a 3.99% increase from 2022.
- Achilles Therapeutics plc annual Operating Income (Loss) for 2022 was -$78.4M, a 22.1% decline from 2021.
- Achilles Therapeutics plc annual Operating Income (Loss) for 2021 was -$64.2M, a 90.3% decline from 2020.
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)